Fundraising FoxQ BioMed
New York, US · Founded 2013 · Nevada corporation
Find your way into Q BioMed
Sign up to see every warm intro you have to Q BioMed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Q BioMed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
WS
William S. RosenstadtExecutive
DC
Denis CorinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.6M disclosed across 6 of 7 rounds · 2016–2021
▶$500KraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William S. RosenstadtExecutive Officer, Director
- Denis CorinExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Aug 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1MraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William S. RosenstadtExecutive Officer, Director
- Denis CorinExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1MraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William S. RosenstadtExecutive Officer, Director
- Denis CorinExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$500KraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Denis CorinExecutive Officer, Director
- William S. RosenstadtExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $500K
- First sale
- Oct 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$3.1MraisedAug 2017 · 18 investors · BiotechnologyRule 506(b)
▶$3.1MraisedAug 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William S. RosenstadtExecutive Officer, Director
- Denis CorinExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Sales commissions
- $20.3K
- Finders' fees
- $102.1K
- Placement agents
- Brookline Capital Markets, a division of CIM Securities, LLC
- First sale
- Aug 2017
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
▶$1.5MraisedDec 2016 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William S. RosenstadtExecutive Officer, Director
- Denis CorinExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.5M
- Minimum investment
- $1.5M
- First sale
- Nov 2016
- Incorporated
- Corporation, Nevada, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Q BioMed raised?
- Q BioMed has disclosed $7.6M raised across 6 of its 7 known rounds.
- Where is Q BioMed headquartered?
- Q BioMed is headquartered in New York, US.